Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Mouse PRSS3 Protein, N-His

Catalog #:   YME06701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q792Z0
Protein length: Ser34-Asn246
Overview

Catalog No.

YME06701

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

Ser34-Asn246

Predicted molecular weight

25.06 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q792Z0

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Mesotrypsin, Serine protease 4, PRSS4, Trypsin-3, Trypsin IV, Mesotrypsinogen, TRY4, Brain trypsinogen, Serine protease 3, TRY3, PRSS3, Trypsin III

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Mouse PRSS3 protein
References

Genetic Markers of Spina Bifida: Enrichment of Pathogenic Variants and Variants of Uncertain Significance., PMID:40191489

Understanding psoriatic disease at single-cell resolution: an update., PMID:40160177

Mendelian randomization of plasma proteomics identifies novel ALS-associated proteins and their GO enrichment and KEGG pathway analyses., PMID:40033250

Cell cycle-based antibody selection for suppressing cancer cell growth., PMID:39953793

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics., PMID:38878676

Exploring Infantile Epileptic Spasm Syndrome: A Proteomic Analysis of Plasma Using the Data-Independent Acquisition Approach., PMID:38857073

PRSS3/mesotrypsin as a putative regulator of the biophysical characteristics of epidermal keratinocytes in superficial layers., PMID:38811772

The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency., PMID:38679185

Evidence that the Bowman-Birk inhibitor from Pisum sativum affects intestinal proteolytic activities in chickens., PMID:37931399

Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics., PMID:37790472

Shear Stress Drives the Cleavage Activation of Protease-Activated Receptor 2 by PRSS3/Mesotrypsin to Promote Invasion and Metastasis of Circulating Lung Cancer Cells., PMID:37395651

Rare variant burden analysis from exomes of three consanguineous families reveals LILRB1 and PRSS3 as potential key proteins in inflammatory bowel disease pathogenesis., PMID:37215724

Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study., PMID:36906533

Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves as a Novel Prognostic Predictor., PMID:36618965

The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis., PMID:36517351

Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma., PMID:36116415

Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer., PMID:36056349

Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication., PMID:35896602

Exome Sequencing Reveals Genetic Variability and Identifies Chronic Prognostic Loci in Chinese Sarcoidosis Patients., PMID:35860586

Immunoassay for trypsinogen-4., PMID:35417678

Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia., PMID:34827175

Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach., PMID:34602499

KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer., PMID:34333552

In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer., PMID:34195683

High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma., PMID:33758142

Mouse model suggests limited role for human mesotrypsin in pancreatitis., PMID:33526384

Dramatic increase in serum trypsinogens, SPINK1 and hCGβ in aortic surgery patients after hypothermic circulatory arrest., PMID:32967482

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer., PMID:32800727

Genetic variants entail type 2 diabetes as an innate immune disorder., PMID:32474106

Induction and recovery of CpG site specific methylation changes in human bronchial cells after long-term exposure to carbon nanotubes and asbestos., PMID:32062310

Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation., PMID:32014997

PRSS contributes to cetuximab resistance in colorectal cancer., PMID:31911942

Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression., PMID:31810373

Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation., PMID:31407378

Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis., PMID:31173193

High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer., PMID:30908656

PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma., PMID:30755669

Serum Serine Peptidase Inhibitor Kazal-Type 1, Trypsinogens 1 to 3, and Complex of Trypsin 2 and α1-Antitrypsin in the Diagnosis of Severe Acute Pancreatitis., PMID:30747826

Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin., PMID:30700553

Single-nucleotide and copy-number variance related to severity of hypospadias., PMID:30078147

Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines., PMID:29629340

Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma., PMID:28844099

Small molecule inhibitors of mesotrypsin from a structure-based docking screen., PMID:28463992

PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast., PMID:28423522

Epithelial expression and function of trypsin-3 in irritable bowel syndrome., PMID:28096305

Retraction Note to: Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer., PMID:27817076

PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration., PMID:27161730

Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy., PMID:26957636

Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer., PMID:26662304

Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2., PMID:26318044

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse PRSS3 Protein, N-His [YME06701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only